日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered extrachromosomal oncogene amplifications promote tumorigenesis

人为引入的染色体外癌基因扩增促进肿瘤发生

Davide Pradella #,Minsi Zhang #,Rui Gao #,Melissa A Yao #,Katarzyna M Gluchowska,Ylenia Cendon-Florez,Tanmay Mishra,Gaspare La Rocca,Moritz Weigl,Ziqi Jiao,Hieu H M Nguyen,Marta Lisi,Mateusz M Ozimek,Chiara Mastroleo,Kevin Chen,Felix Grimm,Jens Luebeck,Shu Zhang ,Andrea Alice Zolli,Eric G Sun,Bhargavi Dameracharla,Zhengqiao Zhao,Yuri Pritykin,Carlie Sigel,Howard Y Chang ,Paul S Mischel,Vineet Bafna,Cristina R Antonescu,Andrea Ventura

Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract

泌尿道透明细胞腺癌的分子、病理和临床特征分析

Rayan Rammal ,Florestan J Koll ,Ziyu Chen ,Jacob E Tallman ,Syed Muneeb Alam ,Jordan E Eichholz ,Walid Chatila ,Tejiri Agbamu ,Andrew T Lenis ,Merve Basar ,Cansu Yol ,Jie-Fu Chen ,Judy Sarungbam ,Ying-Bei Chen ,Anuradha Gopalan ,Samson W Fine ,Satish K Tickoo ,Cristina R Antonescu ,Britta Weigelt ,Nadeem R Abu-Rustum ,Rachel N Grisham ,Amir Momeni-Boroujeni ,Eugene J Pietzak ,Bernard H Bochner ,Jonathan E Rosenberg ,Gopa Iyer ,Victor E Reuter ,David B Solit ,Hikmat Al-Ahmadie

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

治疗引起的衰老有助于 Abemaciclib 对去分化脂肪肉瘤患者的疗效

Caroline E Gleason #, Mark A Dickson #, Mary E Klein Dooley, Cristina R Antonescu, Rodrigo Gularte-Mérida, Marimar Benitez, Juliana I Delgado, Raghu P Kataru, Mark Wei Yi Tan, Martina Bradic, Travis E Adamson, Kenneth Seier, Allison L Richards, Marta Palafox, Eric Chan, Sandra P D'Angelo, Mrinal M G

A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)

MK-2206 治疗无法治愈的腺样囊性癌患者的 2 期研究(联盟 A091104)

Alan L Ho, Nathan R Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R Antonescu, Gary P Frenette, David G Pfister, Charles Erlichman, Gary K Schwartz

Modeling Extraordinary Response Through Targeting Secondary Alterations in Fusion-Associated Sarcoma

通过针对融合相关肉瘤中的继发性改变来建模非凡反应

Fabio Vanoli, Evan Song, Josephine K Dermawan, Eve Fishinevich, Patricia Sung, Soe S Min, Ziyu Xie, Henry de Traux de Wardin, Sinchun Hwang, Robert G Maki, Cristina R Antonescu

Modeling Extraordinary Response Through Targeting Secondary Alterations in Fusion-Associated Sarcoma

通过靶向融合相关肉瘤的继发性改变来模拟非凡的反应

Fabio Vanoli,Evan Song,Josephine K Dermawan,Eve Fishinevich,Patricia Sung,Soe S Min,Ziyu Xie,Henry de Traux de Wardin,Sinchun Hwang,Robert G Maki,Cristina R Antonescu

CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas

CIC-DUX4 染色质分析揭示了 CIC 重排肉瘤中的新表观遗传依赖性和可操作的治疗靶点

Arnaud Bakaric, Luisa Cironi, Viviane Praz, Rajendran Sanalkumar, Liliane C Broye, Kerria Favre-Bulle, Igor Letovanec, Antonia Digklia, Raffaele Renella, Ivan Stamenkovic, Christopher J Ott, Takuro Nakamura, Cristina R Antonescu, Miguel N Rivera, Nicolò Riggi

Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in PDGFRA D842V-Mutant Gastrointestinal Stromal Tumor

肌球蛋白轻链激酶抑制剂增强 Avapritinib 在 PDGFRA D842V 突变型胃肠道间质瘤中的抗肿瘤作用

Ferdinand Rossi, Mengyuan Liu, Andrew Tieniber, Mark S Etherington, Andrew Hanna, Gerardo A Vitiello, Nesteene J Param, Kevin Do, Laura Wang, Cristina R Antonescu, Shan Zeng, Jennifer Q Zhang, Ronald P DeMatteo

Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy

生成 NTRK 融合间充质肿瘤体外模型,作为研究激酶致癌激活和靶向治疗反应的工具

Fabio Vanoli, Laurie Herviou, Yusuke Tsuda, Patricia Sung, Ziyu Xie, Eve Fishinevich, Soe S Min, William Mallen, Henry de Traux de Wardin, Yanming Zhang, Maria Jasin, Cristina R Antonescu

Head and Neck Mesenchymal Tumors with Kinase Fusions: A Report of 15 Cases With Emphasis on Wide Anatomic Distribution and Diverse Histologic Appearance

头颈部间叶性肿瘤伴激酶融合:15 例报告,重点介绍广泛的解剖分布和多样的组织学表现

Bin Xu, Albert J H Suurmeijer, Narasimhan P Agaram, Cristina R Antonescu